05:21 AM EDT, 03/20/2024 (MT Newswires) -- Aquestive Therapeutics ( AQST ) said Tuesday it has priced an underwritten public offering of about 16.7 million common shares at $4.50 per share for gross proceeds of about $75 million.

Underwriters have been granted a 30-day option to purchase up to 2.5 million additional shares

Net proceeds from the offering, which is set to close around Friday, will be used for the development of the company's product pipeline, as well as for general working capital.